These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25306264)

  • 1. Prognostic value of poorly differentiated clusters in invasive breast cancer.
    Sun Y; Liang F; Cao W; Wang K; He J; Wang H; Wang Y
    World J Surg Oncol; 2014 Oct; 12():310. PubMed ID: 25306264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of tumor budding in invasive breast cancer.
    Liang F; Cao W; Wang Y; Li L; Zhang G; Wang Z
    Pathol Res Pract; 2013 May; 209(5):269-75. PubMed ID: 23561623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters.
    Ueno H; Hase K; Hashiguchi Y; Shimazaki H; Tanaka M; Miyake O; Masaki T; Shimada Y; Kinugasa Y; Mori Y; Kishimoto M; Kameoka S; Sato Y; Matsuda K; Nakadoi K; Shinto E; Nakamura T; Sugihara K
    Am J Surg Pathol; 2014 Feb; 38(2):197-204. PubMed ID: 24418853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
    Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
    Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic characteristics and prognosis for molecular subtypes in low-grade breast carcinoma: comparison with grade one invasive ductal carcinoma-not otherwise specified.
    Wang S; Li W; Liu N; Zhang T; Liu H; Liu J; Liu F; Zhang W; Gebreamlak EP; Niu Y
    Med Oncol; 2012 Dec; 29(4):2556-64. PubMed ID: 22311262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.
    Konishi T; Shimada Y; Lee LH; Cavalcanti MS; Hsu M; Smith JJ; Nash GM; Temple LK; Guillem JG; Paty PB; Garcia-Aguilar J; Vakiani E; Gonen M; Shia J; Weiser MR
    Am J Surg Pathol; 2018 Jun; 42(6):705-714. PubMed ID: 29624511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
    Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorly differentiated clusters with larger extents have a greater impact on survival: a semi-quantitative pathological evaluation for 239 patients with non-mucinous pT2-3 colorectal carcinoma.
    Kinoshita O; Kishimoto M; Murayama Y; Yasukawa S; Konishi E; Otsuji E; Yanagisawa A
    World J Surg Oncol; 2015 Apr; 13():140. PubMed ID: 25879220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
    Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
    Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma.
    Yonemura K; Kajiwara Y; Ao T; Mochizuki S; Shinto E; Okamoto K; Hase K; Ueno H
    Am J Surg Pathol; 2019 Oct; 43(10):1341-1348. PubMed ID: 31318710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of poorly differentiated clusters in the primary tumor in patients undergoing hepatectomy for colorectal liver metastasis.
    Ueno H; Konishi T; Ishikawa Y; Shimazaki H; Ueno M; Aosasa S; Saiura A; Hase K; Yamamoto J
    Surgery; 2015 May; 157(5):899-908. PubMed ID: 25731780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer.
    Ammendola S; Turri G; Marconi I; Burato G; Pecori S; Tomezzoli A; Conti C; Pedrazzani C; Barresi V
    Virchows Arch; 2021 Feb; 478(2):241-248. PubMed ID: 32577812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
    Wang K; Zhu GQ; Shi Y; Li ZY; Zhang X; Li HY
    Clin Breast Cancer; 2019 Feb; 19(1):e101-e115. PubMed ID: 30502219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New criteria for histologic grading of colorectal cancer.
    Ueno H; Kajiwara Y; Shimazaki H; Shinto E; Hashiguchi Y; Nakanishi K; Maekawa K; Katsurada Y; Nakamura T; Mochizuki H; Yamamoto J; Hase K
    Am J Surg Pathol; 2012 Feb; 36(2):193-201. PubMed ID: 22251938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
    Serrero G; Hawkins DM; Yue B; Ioffe O; Bejarano P; Phillips JT; Head JF; Elliott RL; Tkaczuk KR; Godwin AK; Weaver J; Kim WE
    Breast Cancer Res; 2012 Feb; 14(1):R26. PubMed ID: 22316048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic impacts of poorly differentiated cluster-based grading system in colorectal carcinoma.
    Kim JW; Shin MK; Kim BC
    J Korean Med Sci; 2015 Jan; 30(1):16-23. PubMed ID: 25552879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prognostic factors in invasive breast cancer with special reference to ductal carcinoma and histologic malignancy grade.
    Garne JP; Aspegren K; Linell F; Rank F; Ranstam J
    Cancer; 1994 Mar; 73(5):1438-48. PubMed ID: 8111711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 36 cases adenoid cystic carcinoma of the breast in China: Comparison with matched grade one invasive ductal carcinoma-not otherwise specified.
    Wang S; Li W; Wang F; Niu Y; Hao C; Wang X; He L; Tong Z
    Pathol Res Pract; 2017 Apr; 213(4):310-315. PubMed ID: 28222936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.